← back to search

Barbara Klughammer

Roche (Switzerland) · CH

Area of research

Pulmonary and Respiratory Medicine · Oncology

Research interest

Research interests include Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment, and Colorectal Cancer Treatments and Studies.

h-index

24

citations

4,290

works

80

NIH funding

—

primary concept

Erlotinib

email

barbara.klughammer@roche.com

Recent publications

Dose escalation to rash for erlotinib plus gemcitabine for metastatic pancreatic cancer: the phase II RACHEL study

British Journal of Cancer 2014cited by 40position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

— · 1 papers (2014–2014)— · 1 papers (2014–2014)Chiun Hsu · National Taiwan University Hospital1 papers (2014–2014)Ali Zeaiter · PharmaMar (Spain)1 papers (2014–2014)Li Cp · Guangxi Medical University1 papers (2014–2014)Eric Van Cutsem · KU Leuven1 papers (2014–2014)Giuseppe Aprile · University of Udine1 papers (2014–2014)Xue Meng · South China Agricultural University1 papers (2014–2014)— · 1 papers (2014–2014)— · 1 papers (2014–2014)Tudor–Eliade Ciuleanu · Iuliu Hațieganu University of Medicine and Pharmacy1 papers (2014–2014)Malcolm J. Moore · University Health Network1 papers (2014–2014)Salomon M. Stemmer · Tel Aviv University1 papers (2014–2014)— · 1 papers (2014–2014)— · 1 papers (2014–2014)Elżbieta Nowara · Amgen (United States)1 papers (2014–2014)